Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus [Yahoo! Finance]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance
PET tracer AT-01 in Phase III and SPECT tracer AT-05 in Phase I of clinical development specifically designed for the diagnosis of cardiac as well as other types of systemic amyloidosis Potential to address the growing need for earlier and accurate diagnosis of these often underdiagnosed conditions AT-01 (124-Iodine-evuzamitide) is first pan-amyloid imaging agent with U.S. FDA Breakthrough Therapy Designation for cardiac amyloidosis; AT-01 also holds Orphan Drug Designation in U.S. and EU Building on its comprehensive radiology portfolio including advanced fluid delivery devices in molecular imaging, Bayer reinforces its ambition to expand in this rapidly growing field by entering the area of diagnostic tracers, while bolstering its position in cardiovascular precision medicine Attralus will now focus on advancing its innovative pan-amyloid removal therapeutics, with AT-02 in Phase II and next generation candidates in preclinical development BERLIN & NAPLES, Fla., January 1
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From AttralusBusiness Wire
- Monsanto Sues COVID-19 Vaccine Manufacturers, Alleging Copyright Infringement [zero hedge]zero hedge
- Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA TherapyBusiness Wire
- Update: Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents [Yahoo! Finance]Yahoo! Finance
- Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents [Yahoo! Finance]Yahoo! Finance